Abstract
In this review, we bring our personal experiences to showcase insulin from its breakthrough discovery as a life-saving drug 100 years ago to its uncovering as the autoantigen and potential cause of type 1 diabetes and eventually as an opportunity to prevent autoimmune diabetes. The work covers the birth of insulin to treat patients, which is now 100 years ago;the development of human insulin, insulin analogs, devices, and the way into automated insulin delivery;the realization that insulin is the primary autoimmune target of type 1 diabetes in children;novel approaches of immunotherapy using insulin for immune tolerance induction;the possible limitations of insulin immunotherapy;and an outlook on how modern vaccines could remove the need for another 100 years of insulin therapy.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 2666-6340 |
Sprache: | Englisch |
Dokumenten ID: | 103344 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:42 |
Letzte Änderungen: | 17. Okt. 2023, 15:13 |